Glucotrack ($GCTK) Rose 73% After Lōkahi Business Combination — Scored 93/100 at 5:40 PM ET
GCTK stock rose 73% after completing its business combination with Lōkahi Therapeutics. RTPR scored the release 93/100 at 5:40 PM ET.
Glucotrack (NASDAQ: GCTK) stock is up today after the company announced completion of its strategic business combination with Lōkahi Therapeutics, rising 73% from its price when the release crossed the wire. RTPR assigned the release an impact score of 93/100 at 5:40 PM ET, when the stock traded at $0.52.
What the release announced
According to the press release (free account required), Glucotrack and Lōkahi Therapeutics completed their strategic business combination. The transaction establishes a publicly listed platform with Lōkahi as the controlling entity, holding approximately 90% ownership of the combined company.
What the stock did
Following the announcement, GCTK traded from $0.52 to post a gain of 73% during the session.
Historical context
This release received an impact score of 93/100.
- Releases scoring 80-100 produced a 15%+ move 50% of the time.
- Sample size: 135 settled outcomes over the past 90 days.
- Historical observations only, not predictions. Full band-by-band table on the impact scoreboard.
Timeline
- 5:40:14 PM ET — press release crossed the wire
- +2 ms — RTPR delivered the release
- 5:40:37 PM ET — impact score written: 93/100
- $0.52 — price at publication
Real-time impact scores on every press release are part of RTPR Pro. Impact scores are in beta; historical tendencies, not predictions or investment advice.